![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/138 | (2006.01) |
A61K 31/138 | (2013.01) | ||
A61K 31/439 | (2006.01) | ||
A61K 31/439 | (2013.01) | ||
A61K 31/58 | (2006.01) | ||
A61K 31/58 | (2013.01) | ||
A61P 11/06 | (2006.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 11/06 | (2018.01) | ||
A61K 9/00 | (2006.01) | ||
A61P 43/00 | (2018.01) | ||
A61K 9/0075 | (2013.01) |
(11) | Patento numeris | 3650019 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 19214674.4 |
Europos patento paraiškos padavimo data | 2015-05-27 | |
(97) | Europos patento paraiškos paskelbimo data | 2020-05-13 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-09-06 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
201462003764 P | 2014-05-28 | US | |
201462004304 P | 2014-05-29 | US | |
201462042506 P | 2014-08-27 | US |
(72) |
BARNES, Neil Christopher , GB
PASCOE, Steven John , US
|
(73) |
GlaxoSmithKline Intellectual Property Development
Limited ,
GSK Medicines Research Centre
Gunnels Wood Road, Stevenage SG1 2NY,
GB
|
(54) | FLUTICASONE FUROATE IN THE TREATMENT OF COPD |
FLUTICASONE FUROATE IN THE TREATMENT OF COPD |